Synopsis

The sponsor provides on an ongoing outpatient basis, high quality early intervention services/primary care to individuals with HIV infection.

Deadline Note

The deadline for receipt of optional letters of intent is September 25, 2006 (for both receipt dates). The deadlines for receipt of full applications are: October 23, 2006; and February 26, 2007.

Synopsis

The sponsor invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes within IDeA-eligible states. This RFA will use the NIH exploratory grant mechanism (P20).

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after May 23, 2006. This program will expire on October 24, 2008.

Synopsis

The sponsor provides support to stimulate and facilitate the entry of promising new investigators into research on arthritis and musculoskeletal and skin diseases and injuries. This solicitation will provide support for pilot research that is likely to lead to a subsequent individual research project grant (R01). This program will use the NIH Small Research Grant (R03) award mechanism.

Deadline Note

This program will expire on June 24, 2008.

Synopsis

The sponsors offer support for individual NRSA postdoctoral fellowships to support the training of physicians with expertise in clinical dermatology to supplement that knowledge with training in epidemiology/clinical trials/outcomes research. These fellowships are intended to support up to two years of advanced training in the relevant methodologies which is to be used to obtain a Master's of Public Health (or similar relevant area of study such as biostatistics, etc) and/or a Ph.D. in epidemiology to qualify the fellow to pursue a career in these areas as they relate to skin diseases. This PAR will use the National Institutes of Health (NIH) Ruth L. Kirschstein Individual Postdoctoral National Research Service Award (NRSA) Fellowship Award (F32) mechanism.

Synopsis

The sponsors offer support for individual NRSA postdoctoral fellowships to support the training of physicians with expertise in orthopaedic surgery to supplement that knowledge with training in epidemiology/clinical trials/outcomes research. These fellowships are intended to support up to two years of advanced training in the relevant methodologies which is to be used to obtain a Master’s of Public Heath (or similar relevant area of study such as biostatistics, etc.) and/or a Ph.D. in epidemiology to qualify the fellow to pursue a career in these areas as they relate to orthopaedic surgery. This PAR will use the National Institutes of Health (NIH) Individual Postdoctoral NRSA Fellowship Award (F32) mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after September 15, 2006. The deadline for receipt of optional letters of intent is September 25, 2006. The deadline for receipt of full applications is October 23, 2006.

Synopsis

The sponsors offer support for proposals to develop high-impact, disruptive technologies for image-guided interventions. As defined here, image-guided interventions (IGI) integrate treatment with imaging technologies at the point of patient care. The long-term goal of the IGI initiative is to produce disruptive technologies that will replace current treatments with minimally invasive, image-guided interventions. A disruptive technology is a new technological innovation that displaces the existing dominant technology. Examples of disruptive technologies include minimally invasive, image-guided procedures that replace invasive surgery or low-cost image-guided interventions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Synopsis

A -- ENHANCING CARBOHYDRATE QUALTIY IN DIABETES MANAGEMENT AND PREVENTION (PRESOL) SOL RFP-NICHD-2007-01 NAICS: 541710 The National Institute of Child Healthand Human Development (NICHD) plans on conducting a study to test the effect ofexposure to behavioral interventions designed to enhance carbohydrate quality in youth with or at risk for diabetes. This study will test an innovative programof interventions designed to promote consumption of lower glycemic carbohydrates from nutrient-dense whole foods and to determine the efficacy of such a dietary change in promoting improved dietary intake and health outcomes among childrenand adolescents with or at risk for diabetes. NICHD anticipates making one award for a 5 year, incrementally funded completion-type contract for this procurement. The contract will have a two year base period and three one year options. RFP No. NICHD 2007-01 will be available electronically on or about July 23, 2006. You can access the RFP through the NICHD website (URL: http://www.fedbizopps.gov) or through the NICHD website (URL http://www.nichd.nih.gov/funding/fudning-opps_rfp.htm). Responses to the RFP will be due on or about October 23, 2006. NICHDwill consider proposals submitted by any responsible offeror. This advertisement does not commit the Government to award a contract. CITE: http://www1.fbo.gov/spg/HHS/NIH/NICHD/RFP%2DNICHD%2D2007%2D01/listing.html Posted 06/23/06 (W-SN01076428). (0174)

Deadline Note

The deadline for receipt of optional letters of intent is October 23, 2006. The deadline for receipt of full applications is November 22, 2006.

Synopsis

The sponsors invite applications from investigators willing to participate in a cooperative research network designed to reduce the incidence of hypoglycemia in children and young adults. The Diabetes Research in Children Network (DirecNet) currently consists of five academic centers selected from among respondents to a previous announcement to support a network focusing on glucose monitoring in children. This RFA serves to expand the mission of DirecNet. The network will use new tools to evaluate factors and mechanisms contributing to hypoglycemia and will set up clinical trials to test novel therapies, prevention strategies and devices designed to focus on hypoglycemia prevention for individuals with type1 diabetes. It is anticipated that a maximum of five awards for Clinical Centers (CCs) and one award for a Data Coordinating Center (DCC) will be made. This program will use the NIH Cooperative Clinical Research (U10) award mechanism for both the DCC and the CCs.

Deadline Note

The deadline for receipt of optional letters of intent is October 23, 2006. The deadline for receipt of full applications is November 21, 2006.

Synopsis

The sponsor offers support for research on chronic orofacial pain disorders that will provide insights into the pathophysiological mechanisms underlying these conditions and the biological mechanisms underlying analgesic treatments of these disorders. This program will use the NIH R01 award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after July 14, 2006. The deadline for receipt of optional letters of intent is October 23, 2006. The deadline for receipt of full applications is November 21, 2006.

Synopsis

The sponsor offers support for research on chronic orofacial pain disorders that will provide insights into the pathophysiological mechanisms underlying these conditions and the biological mechanisms underlying analgesic treatments of these disorders. Two major goals of this funding opportunity are: to stimulate research on patients with chronic painful disorders; and to stimulate the development and utilization of novel animal models of chronic orofacial pain conditions. As an adjunct to these two goals, this Initiative also encourages the development of novel measures of pain in patients and animals that are non-invasive and objective and that permit a behavioral or functional assessment of pain. The primary outcome of this Initiative will be increased knowledge of the biological mechanisms underlying chronic pain disorders, nociception, and analgesic therapies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is September 23, 2006. The deadline for receipt of full applications is October 232, 2006.

Synopsis

The sponsor offers support for early career development of patient oriented researchers in the environmental health sciences. Respondents should propose a multidisciplinary Career Development Program centered on a specific aspect of disease etiology, pathogenesis, progression, and/or epidemiology which will prepare physicians and other doctorally trained scientists to pursue a research career in patient oriented research which has a focus on an environmental exposure relevant to the mission of the NIEHS. Programs must include both a didactic and research career development experience to be guided by a mentoring team. This program will use the NIH Mentored Clinical Scientist Development Award (K12).

Deadline Note

The deadline for receipt of optional letters of intent is September 25, 2006. The deadline for receipt of full applications is October 23, 2006.

Synopsis

The sponsor offers support for research to support the development of novel technologies that will significantly improve the accuracy of comparative modeling methods for protein structure prediction. This program will use the NIH R01 award mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is October 23, 2006. The deadline for receipt of full applications is November 21, 2006.

Synopsis

The sponsor offers support for the establishment of National Centers for Systems Biology. The goal of the program is to promote institutional development of pioneering research, training, and outreach programs focused on systems level analysis of biological phenomena of biomedical importance within the NIGMS mission. The NIGMS supports fundamental inquiries focused on molecular and cell biology, biophysics, genetics and developmental biology, pharmacology, anesthesiology, and human physiology in the areas of trauma, burn, inflammation, and multi-organ failure. This program will use the NIH P50 Specialized Center grant.

Deadline Note

The deadline for receipt of optional letters of intent is October 23, 2006. The deadline for receipt of full applications is November 22, 2006.

Synopsis

The sponsor offers support for Mentored Research Scientists Development Awards limited to health disparities related to aging. This program will use the NIH K01 award mechanism.

Deadline Note

The deadlines for receipt of optional letters of intent are September 25, 2006, and December 29, 2006. The deadliness for receipt of full applications are October 24, 2006, and January 29, 2007. This program will expire on January 30, 2007.

Synopsis

The sponsor offers support for a one to two-year period of research experience for physicians in a residency program through supplements to existing sponsor grant awards. The program targets applicants who have demonstrated the potential for productive research in an area of interest to the candidate and of relevance to the mission of the sponsor. This PAR will use the NIH competitive supplement award mechanism.

Synopsis

The sponsor offers support for the establishment of George M. O'Brien Kidney Research Core Centers to support both basic and clinical research on kidney disease. Core Centers should provide shared institutional and national resources to facilitate basic and clinical research on kidney disease and improve the effectiveness of translating insights from basic biology to clinical practice. The Centers will also support pilot and feasibility studies to develop and test innovative approaches to therapy. This program will use the NIH P30 award mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is October 24, 2006. The deadline for receipt of full applications is November 21, 2006.

Synopsis

The sponsor offers support for the establishment of Research Centers of Excellence in pediatric nephrology. The purpose of the research center is to attract a partnership of interdisciplinary research among investigators with scientific expertise who will use complementary and integrated approaches to study kidney diseases endemic to the pediatric population. In approaching the study of these disease processes it is anticipated that extensive collaboration will be required among individuals in the clinical and basic sciences, including cell biology, molecular biology, immunology, virology, genetics, epidemiology, biochemistry, physiology and pathology. Studies designed to foster and extend the development of new approaches into the causes, early diagnoses, improved treatment, and where possible, prevention of these diseases and disorders are appropriate. This program will use the P50 award mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is October 24, 2006. The deadline for receipt of full applications is November 21, 2006.

Synopsis

The sponsor offers support for Clinical Nutrition Research Unit (CNRU) core centers. The CNRUs are core centers that are part of an integrated program of nutrition and obesity-research support provided by NIDDK. This program will use the NIH Core Center (P30) award mechanism.

Deadline Note

The deadlines for receipt of optional letters of intent are: September 24, 2006; August 10, 2007; and August 10, 2008. The deadlines for receipt of corresponding full applications are: October 24, 2006; September 10, 2007; and September 10, 2008

Synopsis

The sponsor will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training Grants (T32) to eligible institutions to support predoctoral research trainees at the behavioral sciences-biomedical sciences interface. These training programs must include coursework, laboratory rotations and programmatic activities that reinforce training at this interface. Significant participation by faculty and leadership from both behavioral and biomedical science departments is required, as is co-mentoring of trainees by faculty from both components. This program will use the Ruth L. Kirschstein National Research Service Award (NRSA) T32 award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after September 25, 2006. The deadline for receipt of optional letters of intent is September 25, 2006. The deadline for receipt of full applications is October 24, 2006.

Synopsis

The sponsor offers support for systematic scientific study of Elder Mistreatment. This FOA addresses initial scientific stages for understanding Elder Mistreatment in community and institutional settings. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after October 25, 2006.The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. As some technologies that have potential to achieve this goal are already in or near the commercial market, applications to this FOA will need to show clear advantage over current and emerging technologies. Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. This program will use the NIH Phased Innovation (R21/R33) award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after October 25, 2006. The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will enable extremely low-cost DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian-sized genome could be sequenced for approximately $1000. Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas. This program will use the NIH Phased Innovation (R21/R33) award mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. This program will use the NIH Research Project Grant (R01) mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after October 25, 2006. The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will enable extremely low-cost DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian-sized genome could be sequenced for approximately $1000. Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas. This program will use the NIH Research Project Grant (R01) mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after October 25, 2006. The deadline for receipt of optional letters of intent is October 25, 2006. The deadline for receipt of full applications is November 24, 2006.

Synopsis

The sponsor offers support for grant applications to develop novel technologies that will enable extremely low-cost DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian-sized genome could be sequenced for approximately $1000. Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.